Douglas A Marchuk Selected Research

Douglas A Marchuk Research Topics

Disease

17	Central Nervous System Cavernous Hemangioma 05/2022 - 02/2002
11	Hemorrhage 05/2022 - 10/2004
7	Vascular Malformations 10/2021 - 02/2004
6	Hereditary Hemorrhagic Telangiectasia 01/2021 - 02/2004
5	Arteriovenous Malformations (Arteriovenous Malformation) 01/2021 - 02/2004
4	Ischemia 07/2017 - 12/2009
4	Cardiomyopathies (Cardiomyopathy) 01/2013 - 06/2005
4	Hereditary Spastic Paraplegia 05/2010 - 11/2002
3	Infarction (Infarctions) 01/2021 - 01/2013
3	Ischemic Stroke 01/2021 - 01/2016
2	Familial cerebral cavernous malformation 06/2022 - 01/2021
2	Cavernous Hemangioma (Cavernous Angioma) 01/2020 - 01/2019
2	Disease Progression 04/2013 - 01/2013
2	Hemangioma (Angioma) 07/2007 - 03/2002
2	Heart Failure 06/2005 - 12/2003
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2003 - 04/2002
1	Necrosis 07/2017
1	Cerebral Infarction 01/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2014
1	Sturge-Weber Syndrome (Sturge-Kalischer-Weber Syndrome) 05/2013
1	Port-Wine Stain (Nevus Flammeus) 05/2013
1	Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula) 04/2013
1	Brain Injuries (Brain Injury) 01/2013
1	Stroke (Strokes) 01/2013
1	Atrophy 05/2012
1	Inflammation (Inflammations) 02/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2010
1	Heart Diseases (Heart Disease) 09/2009
1	Intermittent Claudication 03/2008
1	Pain (Aches) 03/2008
1	Chronic Limb-Threatening Ischemia 03/2008
1	Myocardial Infarction 01/2008
1	Friedreich Ataxia (Friedreich's Ataxia) 04/2006
1	Vascular Remodeling 03/2005
1	Neoplasms (Cancer) 03/2004
1	Mood Disorders (Mood Disorder) 03/2002

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2002
6	Phosphotransferases (Kinase)IBA 01/2021 - 03/2002
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2012
4	rho-Associated KinasesIBA 01/2020 - 02/2012
4	EndoglinIBA 02/2010 - 02/2004
4	CalsequestrinIBA 09/2009 - 04/2002
3	Propranolol (Inderal)FDA LinkGeneric 01/2022 - 01/2021
3	IronIBA 01/2020 - 01/2016
3	CytokinesIBA 01/2018 - 10/2004
3	SpastinIBA 05/2010 - 09/2004
3	Activin Receptors (Activin Receptor)IBA 12/2008 - 02/2004
2	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2019
2	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2021 - 01/2021
2	Neuroprotective AgentsIBA 01/2021 - 01/2016
2	Pharmaceutical PreparationsIBA 11/2020 - 01/2016
2	fasudil (AT 877)IBA 01/2017 - 02/2012
2	Messenger RNA (mRNA)IBA 01/2013 - 07/2011
2	IntegrinsIBA 01/2013 - 02/2002
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2008 - 03/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2004 - 03/2002
1	Sirolimus (Rapamycin)FDA Link 05/2022
1	CHR 8IBA 01/2021
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2021
1	LipopolysaccharidesIBA 11/2020
1	Versicans (Versican)IBA 10/2020
1	Transcription Factors (Transcription Factor)IBA 10/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2018
1	Green Fluorescent ProteinsIBA 07/2017
1	Simvastatin (Zocor)FDA LinkGeneric 01/2017
1	Interleukin-21 ReceptorsIBA 01/2016
1	Caspase 3 (Caspase-3)IBA 01/2016
1	Heme (Haem)IBA 01/2016
1	Epidermal Growth Factor (EGF)IBA 09/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2015
1	Troponin IIBA 03/2014
1	DNA (Deoxyribonucleic Acid)IBA 05/2013
1	NucleotidesIBA 05/2013
1	LuciferasesIBA 05/2013
1	AntibodiesIBA 05/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2012
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 05/2009
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 02/2009
1	Retinaldehyde (Retinal)IBA 07/2007
1	ApolipoproteinsIBA 05/2006
1	FrataxinIBA 04/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006
1	Transforming Growth Factor-beta Type I ReceptorIBA 03/2005
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2005
1	Complementary DNA (cDNA)IBA 02/2004
1	PhosphotyrosineIBA 12/2003
1	KinesinsIBA 11/2002
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2002
1	Androgen Receptors (Androgen Receptor)IBA 03/2002
1	Carrier Proteins (Binding Protein)IBA 02/2002
1	GTP Phosphohydrolases (GTPases)IBA 02/2002

Therapy/Procedure

4	Therapeutics 01/2022 - 04/2013
1	Aftercare (After-Treatment) 01/2020
1	Limb Salvage 12/2009
1	Surgical Amputation (Amputations) 03/2008